Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
Yuan Yuan, Fan Gao, Ying Chang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
Bolin Wang, Jinli Pei, Shengnan Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 57
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 22
mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
A metal-organic framework (MOF) built on surface-modified Cu nanoparticles eliminates tumors via multiple cascading synergistic therapeutic effects
Guanghui An, Heming Zheng, Lianshan Guo, et al.
Journal of Colloid and Interface Science (2024) Vol. 662, pp. 298-312
Closed Access | Times Cited: 12
Research progress on the quality control of mRNA vaccines
Chaoying Hu, Yu Bai, Jianyang Liu, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 570-583
Open Access | Times Cited: 9
Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 9
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 7
The potential of mRNA vaccines in cancer nanomedicine and immunotherapy
Shulin Pan, Rangrang Fan, Bo Han, et al.
Trends in Immunology (2023) Vol. 45, Iss. 1, pp. 20-31
Closed Access | Times Cited: 18
Emergence of mRNA vaccines in the management of cancer
Mohamad Irfan Mohamad Razif, Nabilah Nizar, Nur Hannah Zainal Abidin, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 629-642
Open Access | Times Cited: 17
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
Alexey D. Perenkov, Alena D. Sergeeva, Maria V. Vedunova, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1600-1600
Open Access | Times Cited: 12
Gastric cancer with brain metastasis: from molecular characteristics and treatment
Yingze Zhu, Miao Zhou, C F Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
A Universal Strategy of Anti‐Tumor mRNA Vaccine by Harnessing “Off‐the‐Shelf” Immunity
Jiayan Fu, Sha Wu, Nan Bao, et al.
Advanced Science (2025)
Open Access
Nano-Oncologic Vaccine for Boosting Cancer Immunotherapy: The Horizons in Cancer Treatment
Chao Chen, Yue‐Ping Xu, Hui Meng, et al.
Nanomaterials (2025) Vol. 15, Iss. 2, pp. 122-122
Open Access
Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies
Wenting Li, Naiming Liu, Mingwei Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189262-189262
Closed Access
Key Considerations for a Prostate Cancer mRNA Vaccine
Guofu Lin, Ahmed Elkashif, Chayanika Saha, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104643-104643
Open Access
Impact of Ionizable Groups in Star Polymer Nanoparticles on NLRP3 Inflammasome Activation
Mehak Malhotra, Sarmishta Madabusi Thodur, Ashish Kulkarni
Biomaterials Science (2025)
Closed Access
Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy
Krishnendu Adhikary, Abhik Paul, А. К. Мадан, et al.
Advances in immunology (2025)
Closed Access
The clinical progress and challenges of mRNA vaccines
Meng‐Zhen Yu, Nannan Wang, Jiaqing Zhu, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 5
Closed Access | Times Cited: 11
The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy
Jingjing Song, Yujun Zhang, Chulin Zhou, et al.
International Immunopharmacology (2024) Vol. 132, pp. 112037-112037
Closed Access | Times Cited: 3
mRNA vaccine development and applications: A special focus on tumors (Review)
Bangjie Chen, Yipin Yang, Xinyi Wang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 2
Closed Access | Times Cited: 3
Scalable multimodal weak anion exchange chromatographic purification for stable mRNA drug substance
Polona Megušar, Rok Miklavčič, Matevž Korenč, et al.
Electrophoresis (2023) Vol. 44, Iss. 24, pp. 1978-1988
Open Access | Times Cited: 7
Path to bacteriotherapy: From bacterial engineering to therapeutic perspectives
Jinling Liu, Chongsheng He, Wenzhi Tan, et al.
Life Sciences (2024) Vol. 352, pp. 122897-122897
Closed Access | Times Cited: 2
The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects
T. P. Chris, Jack Y. Prochnau, A. Mediero Domínguez, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1979-1979
Open Access | Times Cited: 2
Advances and prospects of RNA delivery nanoplatforms for cancer therapy
Mohamed S. Attia, Gregor Kijanka, Nam‐Trung Nguyen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 1, pp. 52-96
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top